Full-Year 2024 Results - Sanofi

Jan 30, 2025 · Full-Year 2024 company sales €41,081m +11.3% at constant exchange rates +8.6% on a reported basis Full-Year 2024 business earnings per share €7.12 +4.1% at …

CouponFollow Extension

3%
OFF

Full-Year 2024 Results - Sanofi

2 weeks from now

Jan 30, 2025 · Full-Year 2024 company sales €41,081m +11.3% at constant exchange rates +8.6% on a reported basis Full-Year 2024 business earnings per share €7.12 +4.1% at …

sanofi.com

$728
OFF

Sanofi: Q4 Earnings Snapshot - Yahoo Finance

2 weeks from now

Jan 30, 2025 · PARIS (AP) — Sanofi (SNY) on Thursday reported fourth-quarter earnings of $728.6 million. The company said it had net income of 29 cents per share. Earnings, adjusted …

yahoo.com

82%
OFF

Sanofi (NASDAQ:SNY) Q4 2024 Earnings Report On 1/30/2025

2 weeks from now

Jan 30, 2025 · View SNY's earnings results, and conference call transcript at MarketBeat. ... Sanofi Q4 2024 Earnings Report $53.35-0.99 (-1.82%) As of 04:00 PM Eastern. ... Expected …

marketbeat.com

$728
OFF

Sanofi: Q4 Earnings Snapshot - CT Insider

2 weeks from now

Jan 30, 2025 · PARIS (AP) — PARIS (AP) — Sanofi (SNY) on Thursday reported fourth-quarter earnings of $728.6 million. The company said it had net income of 29 cents per share. …

ctinsider.com

$5.21
OFF

Sanofi Meets Estimates For Fourth-quarter Profit, Plans 5 Billion …

2 weeks from now

Jan 30, 2025 · French drugmaker Sanofi reported a fourth-quarter profit that came in-line with analysts' estimates on Thursday, and said it would buy back 5 billion euros ($5.21 billion) in …

yahoo.com

7%
OFF

Merck Announces Fourth-Quarter And Full-Year 2024 Financial …

2 weeks from now

3 days ago · Fourth-Quarter Worldwide Sales Were $15.6 Billion, an Increase of 7% From Fourth Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 9% Fourth-Quarter …

merck.com

1%
OFF

Cummins Reports Strong Fourth Quarter And Full Year 2024 …

2 weeks from now

3 days ago · Earnings before interest, taxes, depreciation and amortization (EBITDA) in the fourth quarter were $1.0 billion, or 12.1% of sales, compared to a loss of $878 million, or negative …

cummins.com

$722
OFF

Chevron Reports Fourth Quarter 2024 Results

2 weeks from now

Jan 31, 2025 · Foreign currency effects increased earnings by $722 million. Adjusted earnings of $3.6 billion ($2.06 per share - diluted) in fourth quarter 2024 compared to adjusted earnings of …

chevron.com

FAQs about Full-Year 2024 Results - Sanofi Coupon?

What was Sanofi's fourth-quarter earnings?

PARIS (AP) — PARIS (AP) — Sanofi (SNY) on Thursday reported fourth-quarter earnings of $728.6 million. The company said it had net income of 29 cents per share. Earnings, adjusted for non-recurring costs and to account for discontinued operations, came to 70 cents per share. The results did not meet Wall Street expectations. ...

When will Sanofi report fourth-quarter results?

Sanofi is scheduled to report results for the fourth quarter on Thursday. Here is what you need to know. SALES FORECAST: Analysts expect the French pharmaceutical giant to report fourth-quarter sales of 10.39 billion euros ($10.90 billion), according to a Vara Research poll. ...

How did Sanofi perform in Q4 2024?

Q4 2024 net sales increased by 10.3% to 10.6 billion euros. Business EPS rose by 4.1%, exceeding full-year guidance. Dupixent sales surpassed the 13 billion euro target, growing by 23%. Sanofi announced a 5 billion euro share buyback for 2025. The company proposed a 3.92 euro dividend per share, marking the 30th consecutive year of increase. ...

Did Sanofi announce a 5 billion share buyback for 2025?

Sanofi announced a 5 billion euro share buyback for 2025. The company proposed a 3.92 euro dividend per share, marking the 30th consecutive year of increase. Sanofi's performance in the fourth quarter of 2024 was marked by strong sales growth across its product lines, particularly in immunology and vaccines. ...

Does Sanofi have Quarterly calls?

Thomas, Vaccines Business Leader, Sanofi: Yes. And if I cannot answer them specifically, please go. That's why we're having quarterly calls. It might be some other quarters on the road. What I mean by that sorry, Joe. And back to your first question on the penetration in the U. S. ...

How will Sanofi perform in 2025?

Sanofi expects mid to high single-digit sales growth in 2025, with business EPS projected to grow in the low double digits at constant exchange rates. The company anticipates a positive foreign exchange impact of 2-3% and remains committed to investing in research and development, manufacturing, and digital technologies. ...